Manus parent says it raised more than $500 million; $4 billion valuation unconfirmed

SiliconANGLE also reported that Manus raised $75 million from Benchmark in April 2025. The new round is a much larger financing, but a single company’s fundraising does not show whether investors are making similar bets across the agent sector. The available reports identify participants and the amount; they do not provide wider investment data that would establish a market-wide trend.

That distinction matters because the capital is a concrete commitment to Butterfly Effect, while customer uptake is a separate question. A large round can show that investors are willing to finance Manus; it cannot, on its own, show how many people pay for the product, how often they use it or whether they continue using it.

The $4 billion figure was an expectation

The $4 billion valuation came from an earlier report, not from confirmed terms for the completed financing. On Sept. 17, Bloomberg reported that a planned $500 million round was expected to value Manus at $4 billion. Bloomberg said discussions were ongoing and that terms could change.

The later reports establish that Butterfly Effect completed a round above $500 million. They do not confirm the final valuation. Treating the earlier figure as a completed deal term would turn a reported expectation into a fact the financing coverage does not establish.

The financing also follows the unwinding of Meta’s proposed acquisition, which Reuters described as worth more than $2 billion. That proposed deal is relevant context for Manus’s return to independent operations, but it was not a completed sale and does not establish the company’s value in this round.

Revenue and product claims leave gaps

There is a separate report of substantial commercial activity, but it is not audited evidence of adoption. The Information reported in June that Manus had an annualized revenue run rate of $400 million to $500 million, citing people familiar with the company’s finances. The report does not supply audited revenue, customer counts or retention figures that would show how many customers generated that revenue or how durable their use was.

Reuters describes Manus as a general-purpose agent for tasks such as research and automation. SiliconANGLE reported the rollout of Manus 2.0 and attributed performance figures to the company, including processing more than 28% faster on some tasks. That is a company-reported result, not an independently verified measurement; the coverage does not cite outside testing.

Taken together, the reports establish a large financing, named investors and a separate estimate of revenue pace. They do not settle the final valuation or show whether Manus has sustained customer use, and they do not independently validate the product’s performance claims. Audited financials, customer and retention data, and independent product tests would provide evidence the funding announcement cannot.